Point72 Middle East FZE’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-27,463
Closed -$1.87M 1607
2023
Q3
$1.87M Buy
+27,463
New +$2.33M 0.06% 375
2023
Q2
Sell
-73,850
Closed -$5.01M 1698
2023
Q1
$5.01M Buy
73,850
+43,052
+140% +$2.77M 0.17% 156
2022
Q4
$1.52M Buy
+30,798
New +$1.26M 0.07% 377

Other funds holding EXAS

Point72 Middle East FZE's EXAS Position: Q4 2023 in Review

Point72 Middle East FZE sold out of Exact Sciences (EXAS) in Q4 2023, closing a stake of 27,463 shares — an estimated $1.87M sold.

Point72 Middle East FZE first reported a position in EXAS in Q4 2022 and held it in 3 quarters. The position peaked at $5.01M in Q1 2023. 646 funds tracked by Wall St. Rank hold EXAS as of Q4 2023.

  • Point72 Middle East FZE reported no remaining Exact Sciences position as of Q4 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 27,463 Exact Sciences shares in Q4 2023, an estimated $1.87M.
  • Point72 Middle East FZE first reported a position in Exact Sciences in Q4 2022 and held it in 3 quarters.
  • Point72 Middle East FZE's Exact Sciences position peaked at $5.01M in Q1 2023.
  • 646 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2023.

Based on Point72 Middle East FZE's 13F filing for Q4 2023, filed 14 Feb 2024.